Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Introduction of Differential KIR Activation Mediated Patters of NK Cell Cytotoxicity Against Myeloma

Thomas StÜbig, York Hildebrand, Karla Jungk, Aga Konielsk, Lars Lange, Thomas Binder, Heidi Duske, Djordje Atanackovic, Boris Fehse, Thomas Eiermann, Axel R. Zander, MD, Nicolaus Kröger, MD

Blood (2010) 116 (21): 5178.

https://doi.org/10.1182/blood.V116.21.5178.5178

Published: 2010

Journal Articles

Donor KIR-Haplotype B Improved Relapse-Free Survival After Allogeneic Stem Cell Transplantation for Multiple Myeloma

Nicolaus Kröger, Heidi Duske, Tatjana Zabelina, Thomas Binder, Boris Fehse, Orhan Sezer, MD, PhD, Thomas Stübig, York Hildebrandt, Djordje Atanackovic, Axel R. Zander, MD, Thomas Eiermann

Blood (2010) 116 (21): 2373.

https://doi.org/10.1182/blood.V116.21.2373.2373

Published: 2010

Journal Articles

Outcome of HLA-Mismatched Unrelated Donor Allogeneic Stem Cell Transplantation Depends On the Intensity of the Conditioning Regimen.

Francis Ayuk, MD, Tatjana Zabelina, MD, Ulrike Bacher, MD, Christine Wolschke, MD, Heinrich Lellek, MD, Thomas Eiermann, MD, Rudolf Erttmann, MD, Nicolaus Kröger, MD, Axel R. Zander, MD

Blood (2009) 114 (22): 3393.

https://doi.org/10.1182/blood.V114.22.3393.3393

Published: 2009

Journal Articles

Comparable Results of HLA-Mismatched Vs HLA-Matched Unrelated Donors for Allogeneic Stem Cell Transplantation Using Pre-Transplant ATG.

Nicolaus Kroeger, Tatjana Zabelina, Thomas Binder, Francis Ayuk, Ulrike Bacher, Gitta Amtsfeld, Alexander Muth, Heinrich Lellek, Rudolf Erttmann, Christine Wolschke, Thomas Eiermann, Axel R. Zander

Blood (2008) 112 (11): 966.

https://doi.org/10.1182/blood.V112.11.966.966

Published: 2008

Journal Articles

Cancer-testis antigens are commonly expressed in multiple myeloma and induce systemic immunity following allogeneic stem cell transplantation

Djordje Atanackovic, Julia Arfsten, Yanran Cao, Sacha Gnjatic, Frank Schnieders, Katrin Bartels, Georgia Schilling, Christiane Faltz, Christine Wolschke, Judith Dierlamm, Gerd Ritter, Thomas Eiermann, Dieter Kurt Hossfeld, Axel R. Zander, Achim A. Jungbluth, Lloyd J. Old, Carsten Bokemeyer, Nicolaus Kröger

Blood (2006) 109 (3): 1103–1112.

https://doi.org/10.1182/blood-2006-04-014480

Published: 2006

Includes: Supplemental data

Journal Articles

MTHFR-A1298C Polymorphism Is Associated with Veno-Occlusive Disease (VOD) and Liver Toxicity after Busulfan/Cyclophosphamide Conditioning Followed by Allogeneic Hematopoietic Stem Cell Transplantation (HSCT).

Eray Goekkurt, MD, Jan Stoehlmacher, MD, Christian Stueber, Christine Wolschke, MD, Tatjana Zabelina, MD, Thomas Eiermann, MD, Thomas Binder, MD, Simona Iacobelli, Axel R. Zander, MD, Nicolaus Kröger, MD

Blood (2005) 106 (11): 2730.

https://doi.org/10.1182/blood.V106.11.2730.2730

Published: 2005

Journal Articles

Comparison between Anti-Thymocyte Globulin and Alemtuzumab and the Possible Impact of KIR-Ligand Mismatch in Melphalan/Fludarabine Dose-Reduced Conditioning Followed by HLA-Matched and Mismatched Unrelated Stem Cell Transplantation in Patients with Multiple Myeloma.

Nicolaus Kroeger, MD, Brownen Shaw, MD, Simona Iacobelli, PhD, Tatjana Zabelina, MD, Karl Peggs, MD, Avichai Shimoni, MD, Arnon Nagler, MD, Thomas Binder, MD, PhD, Rainer Schwerdtfeger, MD, Michael Kiehl, MD, Herbert G. Sayer, MD, Francis Ayuk, MD, Thomas Eiermann, MD, PhD, David Marks, MD

Blood (2004) 104 (11): 980.

https://doi.org/10.1182/blood.V104.11.980.980

Published: 2004

NARROW

Introduction of Differential KIR Activation Mediated Patters of NK Cell Cytotoxicity Against Myeloma

Donor KIR-Haplotype B Improved Relapse-Free Survival After Allogeneic Stem Cell Transplantation for Multiple Myeloma

Outcome of HLA-Mismatched Unrelated Donor Allogeneic Stem Cell Transplantation Depends On the Intensity of the Conditioning Regimen.

Comparable Results of HLA-Mismatched Vs HLA-Matched Unrelated Donors for Allogeneic Stem Cell Transplantation Using Pre-Transplant ATG.

Cancer-testis antigens are commonly expressed in multiple myeloma and induce systemic immunity following allogeneic stem cell transplantation

MTHFR-A1298C Polymorphism Is Associated with Veno-Occlusive Disease (VOD) and Liver Toxicity after Busulfan/Cyclophosphamide Conditioning Followed by Allogeneic Hematopoietic Stem Cell Transplantation (HSCT).

Comparison between Anti-Thymocyte Globulin and Alemtuzumab and the Possible Impact of KIR-Ligand Mismatch in Melphalan/Fludarabine Dose-Reduced Conditioning Followed by HLA-Matched and Mismatched Unrelated Stem Cell Transplantation in Patients with Multiple Myeloma.

Email alerts

ASH Publications

American Society of Hematology

Introduction of Differential KIR Activation Mediated Patters of NK Cell Cytotoxicity Against Myeloma

Donor KIR-Haplotype B Improved Relapse-Free Survival After Allogeneic Stem Cell Transplantation for Multiple Myeloma

Outcome of HLA-Mismatched Unrelated Donor Allogeneic Stem Cell Transplantation Depends On the Intensity of the Conditioning Regimen.

Comparable Results of HLA-Mismatched Vs HLA-Matched Unrelated Donors for Allogeneic Stem Cell Transplantation Using Pre-Transplant ATG.

Cancer-testis antigens are commonly expressed in multiple myeloma and induce systemic immunity following allogeneic stem cell transplantation

MTHFR-A1298C Polymorphism Is Associated with Veno-Occlusive Disease (VOD) and Liver Toxicity after Busulfan/Cyclophosphamide Conditioning Followed by Allogeneic Hematopoietic Stem Cell Transplantation (HSCT).

Comparison between Anti-Thymocyte Globulin and Alemtuzumab and the Possible Impact of KIR-Ligand Mismatch in Melphalan/Fludarabine Dose-Reduced Conditioning Followed by HLA-Matched and Mismatched Unrelated Stem Cell Transplantation in Patients with Multiple Myeloma.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only